Trials / Completed
CompletedNCT02430766
Irreversible Electroporation(IRE) For Unresectable Lymph Node Metastases(Close to Nerve)
Irreversible Electroporation(IRE) For Unresectable Lymph Node Metastases: Phase I and Phase II Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Fuda Cancer Hospital, Guangzhou · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for unresectable Lymph Node Metastases.
Detailed description
By enrolling patients with unresectable Lymph Node Metastases adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of percutaneous IRE for unresectable Lymph Node Metastases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Irreversible electroporation (IRE) | Irreversible Electroportion For Unresectable Lymph Node Metastases guide with ultrasound or/and CT. |
| DEVICE | NanoKnife |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2020-12-01
- Completion
- 2021-02-01
- First posted
- 2015-04-30
- Last updated
- 2021-09-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02430766. Inclusion in this directory is not an endorsement.